Author:
Maurits J. S. F.,Sedelaar J. P. M.,Aben K. K. H.,Kiemeney L. A. L. M.,Vrieling A.
Abstract
AbstractHigher BMI has been associated with lower tumor stage and grade and improved survival in renal cell cancer (RCC). BMI cannot distinguish between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). We examined associations of BMI, VAT, SAT, total adipose tissue (TAT) and relative VAT (rVAT) with tumor stage and grade in RCC patients. In a Dutch multicenter population-based historical cohort study 1039 RCC patients diagnosed between 2008 and 2012 were assessed for VAT and SAT using Computed Tomography images at L3. Sex-stratified multinomial logistic regression analyses were performed (linearly per 10-unit increase) between BMI, VAT, SAT, TAT and relative VAT (rVAT) with tumor stage and Fuhrman grade. Higher VAT, TAT and rVAT were associated with a lower risk of stage IV versus stage I in males (OR 0.93; 95%CI 0.91–0.96, OR 0.95; 95%CI 0.93–0.98, OR 0.97; 95%CI 0.96–0.99, respectively). Females showed similar associations, but only higher VAT was statistically significantly associated with reduced risk of stage IV (OR 0.95 95%CI 0.89–1.00). No associations with grade, SAT or BMI were found. In conclusion, higher VAT and TAT was associated with lower risk of stage IV RCC. This might be due to weight loss or cancer cachexia in stage IV patients.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. Continuous Update Project Expert Report 2018. dietandcancerreport.org.
2. Kim, L. H. et al. A systematic review and meta-analysis of the significance of body mass index on kidney cancer outcomes. J. Urol. 205, 346–355. https://doi.org/10.1097/JU.0000000000001377 (2021).
3. Balci, M. et al. Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma. J. Cancer Res. Ther. 17, 420–425. https://doi.org/10.4103/jcrt.JCRT_546_18 (2021).
4. Parker, A. S. et al. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology 68, 741–746. https://doi.org/10.1016/j.urology.2006.05.024 (2006).
5. Jeon, H. G. et al. Prognostic value of body mass index in Korean patients with renal cell carcinoma. J. Urol. 183, 448–454. https://doi.org/10.1016/j.juro.2009.10.004 (2010).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献